Preparation of a vaccine (illustration).
-
Keith Birmingham / AP / SIPA
US pharmaceutical giant Pfizer plans to seek emergency authorization for its Covid-19 vaccine from US authorities in the third week of November, its CEO announced on Friday.
“Let me be clear, assuming the data is positive, Pfizer will apply for emergency use authorization in the United States shortly after the safety milestone has been passed, during the third week of November, ”said Albert Bourla in an open letter posted on social networks.
… /… More information to come on
20 Minutes
World
Facebook bans ads discouraging getting vaccinated
World
World Bank releases $ 12 billion for vaccines
Health
Laboratory
Covid 19
Vaccine
Coronavirus